NCT00483535 - Oral Contraceptive Interaction Study for GW273225 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 7, 2007

Primary Completion Date

November 16, 2007

Study Completion Date

November 16, 2007

Conditions

Bipolar Disorder

Interventions

DRUG

GW273225

GW273225 will be available as 25 milligram tablets.

DRUG

COC

COC will consist of Microgynon 30 which is available as ethinylestradiol 30 micrograms/levonorgestrel 150 micrograms beige color, sugar-coated tablets.

Trial Locations (1)

CB3 7TR

GSK Investigational Site, Cambridge